申请人:Centre Régional de Lutte contre le Cancer -
Centre François Baclesse
公开号:EP3878847A1
公开(公告)日:2021-09-15
The present invention relates to compounds, compositions and methods for treating cancers and disorders of cell proliferation and more particularly, methods of making and using compounds that modulate at least one of the proteins chosen from Bcl-2, Mcl-1, Bcl-xL, Bcl-w, Bfl-1 and Bcl-B, in particular Bcl-2 protein, or Bcl-xL and/or Mcl-1 proteins; said compounds may be contained in pharmaceutical compositions and used as therapeutic agents.
本发明涉及用于治疗癌症和细胞增殖紊乱的化合物、组合物和方法,更具体地说,涉及制造和使用可调节选自 Bcl-2、Mcl-1、Bcl-xL、Bcl-w、Bfl-1 和 Bcl-B 的至少一种蛋白质(尤其是 Bcl-2 蛋白质)或 Bcl-xL 和/或 Mcl-1 蛋白质的化合物的方法;所述化合物可包含在药物组合物中并用作治疗剂。